Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mittelman

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Harefuah|April 1, 1992
[The myelodysplastic syndrome]M Mittelman
Israel Journal of Medical Sciences|December 1, 1996
Anemia of cancer: pathogenesis and treatment with recombinant erythropoietinM Mittelman
Acta Haematologica|January 1, 1993
Recombinant erythropoietin in myelodysplastic syndromes: whom to treat and how? More questions than answersM Mittelman
Harefuah|June 1, 1993
[Molecular genetics in hematology--from the laboratory bench to beside application]M Mittelman
Israel Journal of Medical Sciences|August 1, 1990
The myelodysplastic syndromes--1990M Mittelman
International Journal of Hematology|April 4, 2000
Platelet function in the myelodysplastic syndromesM Mittelman, A Zeidman
Annals of Internal Medicine|July 1, 1993
Predicting response to recombinant human erythropoietinM Mittelman, S Floru
Harefuah|June 1, 1983
[Immunological markers in acute leukemia and their use in typing and differential diagnosis]M Mittelman, M Djaldetti
Hematology/Oncology Clinics of North America|October 1, 1994
Clinical application of recombinant erythropoietin in myelodysplasiaM Mittelman, L S Lessin
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1984
Effect of human saliva on the phagocytotic activity of polymorphonuclear leukocytes and monocytesM Mittelman, P Fishman, M Djaldetti
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Harefuah|April 1, 1992
[The myelodysplastic syndrome]M Mittelman
Israel Journal of Medical Sciences|December 1, 1996
Anemia of cancer: pathogenesis and treatment with recombinant erythropoietinM Mittelman
Acta Haematologica|January 1, 1993
Recombinant erythropoietin in myelodysplastic syndromes: whom to treat and how? More questions than answersM Mittelman
Harefuah|June 1, 1993
[Molecular genetics in hematology--from the laboratory bench to beside application]M Mittelman
Israel Journal of Medical Sciences|August 1, 1990
The myelodysplastic syndromes--1990M Mittelman
International Journal of Hematology|April 4, 2000
Platelet function in the myelodysplastic syndromesM Mittelman, A Zeidman
Annals of Internal Medicine|July 1, 1993
Predicting response to recombinant human erythropoietinM Mittelman, S Floru
Harefuah|June 1, 1983
[Immunological markers in acute leukemia and their use in typing and differential diagnosis]M Mittelman, M Djaldetti
Hematology/Oncology Clinics of North America|October 1, 1994
Clinical application of recombinant erythropoietin in myelodysplasiaM Mittelman, L S Lessin
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1984
Effect of human saliva on the phagocytotic activity of polymorphonuclear leukocytes and monocytesM Mittelman, P Fishman, M Djaldetti
Pageof 12